+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Apheresis Equipment Market - Global Forecast 2026-2032- Product Image
Apheresis Equipment Market - Global Forecast 2026-2032- Product Image
Sale

Apheresis Equipment Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5305533
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Apheresis Equipment Market is projected to reach USD 3.78 Billion in 2026. It is expected to continue growing at a CAGR of 9.33%, reaching USD 6.45 Billion by 2032.

Apheresis equipment is central to modern transfusion medicine, therapeutic apheresis, stem cell collection, and plasma-derived therapies. These systems separate whole blood into components such as plasma, platelets, red cells, leukocytes, or hematopoietic stem cells, enabling targeted collection or removal while returning remaining components to the donor or patient.

The market is supported by well-established clinical use cases, including plateletpheresis, plasmapheresis, leukapheresis, extracorporeal photopheresis support workflows, and therapeutic plasma exchange. Demand is reinforced by aging populations, cancer care expansion, autoimmune and hematologic disease management, trauma preparedness, and continued reliance on plasma fractionation for immunoglobulins, albumin, and coagulation factors.

Transformative Shifts in the Apheresis Landscape

The apheresis equipment landscape is shifting from manual, labor-intensive workflows toward automated, software-guided systems designed to improve collection efficiency, operator consistency, and patient safety. Modern platforms increasingly emphasize closed or functionally closed fluid pathways, integrated anticoagulant control, automated interface detection, configurable protocols, and real-time procedure monitoring.

A second transformation is the convergence of apheresis with cell and gene therapy supply chains. Leukapheresis and mononuclear cell collection are critical upstream steps for CAR-T and other advanced therapies, making collection quality, chain-of-identity controls, chain-of-custody documentation, and digital traceability strategic differentiators for hospitals, blood centers, and therapy developers.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence apheresis equipment through decision support rather than autonomous clinical replacement. AI-enabled analytics can support donor and patient scheduling, procedure parameter optimization, adverse event risk flagging, inventory planning, quality trend detection, and predictive maintenance for high-utilization blood center and hospital environments.

The cumulative impact depends on governance. AI applications connected to apheresis workflows must align with medical device quality systems, cybersecurity expectations, clinical validation, data privacy laws such as HIPAA and GDPR, and internationally recognized risk management practices such as ISO 14971. The strongest near-term value is expected in workflow efficiency, quality assurance, utilization management, and equipment uptime.

Key Regional Insights

Asia-Pacific is expanding through rising healthcare investment, large patient populations, increasing oncology care, and growing demand for plasma-derived medicinal products. China, India, Japan, South Korea, and Australia are important anchors, with Japan and Australia supported by mature transfusion systems and China and India advancing capacity across hospitals, blood services, and specialty centers.

North America remains a high-adoption region because of established blood collection infrastructure, FDA-regulated device pathways, strong therapeutic apheresis use, active cellular therapy programs, and extensive plasma collection activity. Latin America shows selective expansion led by Brazil and Mexico, where private hospital networks, public health investment, and tertiary care development support demand for donor and therapeutic apheresis. Europe benefits from structured hemovigilance, EU medical device regulation, mature transfusion networks, and advanced hospital systems, while the Middle East is investing in tertiary care capacity, oncology services, and national health infrastructure, particularly in GCC countries. Africa’s opportunity is tied to blood safety modernization, donor infrastructure, infectious disease screening capacity, and improved access to specialty treatment in major urban medical centers.

Key Group Insights

ASEAN demand is shaped by hospital modernization, improving blood services, medical tourism, and expanding private healthcare networks in countries such as Singapore, Thailand, Malaysia, Indonesia, and Vietnam. The GCC is investing in specialty hospitals, oncology services, transplant programs, and national self-sufficiency goals, creating demand for reliable therapeutic apheresis and donor collection systems.

The European Union is defined by stringent quality, safety, and regulatory requirements, including medical device conformity, blood establishment standards, hemovigilance, and cross-border healthcare quality frameworks. BRICS countries represent scale-driven opportunity, especially where plasma demand, oncology care, and cell therapy programs are expanding alongside broader healthcare infrastructure. G7 markets lead in clinical adoption, reimbursement maturity, evidence-based protocols, and advanced therapy integration, while NATO countries emphasize resilient blood supply chains, emergency preparedness, interoperable healthcare logistics, and continuity of critical medical services.

Key Country Insights

The United States leads in plasma collection scale, therapeutic apheresis adoption, and advanced cellular therapy infrastructure, while Canada benefits from organized blood systems, strong hospital-based care, and established clinical governance. Mexico and Brazil are expanding access through public and private healthcare investment, with Brazil serving as a key Latin American healthcare hub for tertiary care, transfusion services, and specialty medicine.

The United Kingdom, Germany, France, Italy, and Spain maintain advanced transfusion and hospital networks supported by clinical standards, hemovigilance practices, and specialist treatment pathways, while Germany is especially notable for high medical technology adoption and robust hospital infrastructure. Russia has a broad hospital base but faces procurement, access, and supply chain constraints. China and India offer large-volume demand potential driven by population scale, oncology expansion, blood service development, and healthcare investment; Japan and South Korea provide technologically mature markets supported by high clinical standards and advanced hospital systems; and Australia combines strong transfusion governance, high clinical quality expectations, and regional reference capabilities across the Asia-Pacific healthcare ecosystem.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize platforms that reduce operator variability, improve collection yield, enhance patient and donor safety, and integrate seamlessly with blood bank information systems, hospital electronic records, laboratory systems, and cell therapy manufacturing workflows. Investments in closed-system design, consumable reliability, cybersecurity, remote diagnostics, and service responsiveness can strengthen competitive positioning.

Manufacturers and providers should also build evidence packages around procedure efficiency, adverse event reduction, product quality, staff workflow, training efficiency, and total cost of ownership. Partnerships with blood centers, oncology networks, transplant programs, and cell therapy developers can accelerate adoption, while regulatory-ready AI governance and validated digital traceability can create durable differentiation.

Research Methodology

The research approach combines secondary research from regulatory authorities, public health agencies, clinical guidelines, scientific literature, healthcare infrastructure data, and publicly available industry documentation. Sources typically include FDA device information, European regulatory frameworks, WHO blood safety resources, transfusion medicine guidance, clinical practice recommendations, and peer-reviewed publications.

Market interpretation is strengthened through triangulation across device adoption patterns, procedure volumes where publicly available, disease burden indicators, blood and plasma collection trends, hospital capacity, reimbursement context, regulatory requirements, and procurement behavior. Insights are validated by comparing regional dynamics, clinical use cases, technology readiness, and healthcare system maturity across established and emerging markets.

Conclusion

Apheresis equipment is moving from specialized transfusion infrastructure toward a strategic platform for precision medicine, plasma supply, therapeutic intervention, and advanced therapy manufacturing. Growth drivers are supported by clinical necessity, technology automation, digital traceability, and rising demand for safe, standardized blood component collection and therapeutic procedures.

The strongest market participants will combine clinical reliability, digital interoperability, regulatory discipline, service excellence, and evidence-based value demonstration. As AI, cell therapy, plasma-derived medicine demand, and regional healthcare investment reshape adoption priorities, apheresis equipment providers that deliver measurable workflow, safety, and quality improvements will be best positioned for long-term growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Apheresis Equipment Market, by Product Type
7.1. Introduction
7.2. Disposable Apheresis Kits
7.2.1. Blood Tubing Sets
7.2.2. Filters
7.2.3. Needles & Catheters
7.3. Apheresis Devices
7.3.1. Automated Apheresis Machines
7.3.2. Semi-Automated Apheresis Machines
8. Apheresis Equipment Market, by Technology Type
8.1. Introduction
8.2. Centrifugation Technology
8.3. Membrane Filtration Technology
8.3.1. Hollow Fiber Filtration
8.3.2. Selective Plasma Filtration
8.4. Adsorption Technology
8.5. Photopheresis Technology
9. Apheresis Equipment Market, by Patient Type
9.1. Introduction
9.2. Adult
9.3. Pediatric
10. Apheresis Equipment Market, by Application
10.1. Introduction
10.2. Blood Collection
10.2.1. Plasma Collection
10.2.2. Platelet Collection
10.2.3. RBC Collection
10.2.4. Stem Cell Collection
10.3. Therapeutic
10.3.1. Neurological Disorders
10.3.1.1. Guillain-Barre Syndrome
10.3.1.2. Myasthenia Gravis
10.3.1.3. Multiple Sclerosis
10.3.2. Hematological Disorders
10.3.2.1. Leukemia
10.3.2.2. Sickle Cell Disease
10.3.2.3. Thrombocytopenia
10.3.3. Renal Diseases
10.3.3.1. Kidney Failure
10.3.3.2. Glomerulonephritis
10.3.4. Autoimmune Diseases
11. Apheresis Equipment Market, by End User
11.1. Introduction
11.2. Blood Banks
11.3. Specialty Clinics
11.4. Hospitals
11.4.1. Public Hospitals
11.4.2. Private Hospitals
11.5. Research Institutes
12. Apheresis Equipment Market, by Distribution Channel
12.1. Introduction
12.2. Online
12.3. Offline
13. Apheresis Equipment Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Apheresis Equipment Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Apheresis Equipment Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Aferetica srl
17.2. Asahi Kasei Medical Co., Ltd.
17.3. B. Braun SE
17.4. Baxter International Inc.
17.5. Beijing ZKSK Technology Co., Ltd.
17.6. Bioelettronica S.r.l.
17.7. Cerus Corporation
17.8. Cytosorbents Corporation
17.9. Fresenius SE & Co. KGaA
17.10. Guangzhou Daji Medical Science and Technology Co., Ltd.
17.11. Haemonetics Corporation
17.12. Haier Biomedical
17.13. Infomed SA
17.14. Jafron Biomedical Co., Ltd.
17.15. Kaneka Corporation
17.16. Kawasumi Laboratories, Inc.
17.17. Macopharma SA
17.18. Medica S.p.A.
17.19. Miltenyi Biotec B.V. & Co. KG
17.20. Nikkiso Co., Ltd.
17.21. PuriBlood Medical Co., Ltd.
17.22. Terumo BCT, Inc.
17.23. Therakos, Inc.
List of Figures
FIGURE 1. GLOBAL APHERESIS EQUIPMENT MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL APHERESIS EQUIPMENT MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL APHERESIS EQUIPMENT MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL APHERESIS EQUIPMENT MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 17. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL APHERESIS EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL APHERESIS EQUIPMENT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL APHERESIS EQUIPMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL DISPOSABLE APHERESIS KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL DISPOSABLE APHERESIS KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL DISPOSABLE APHERESIS KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL BLOOD TUBING SETS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL BLOOD TUBING SETS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL BLOOD TUBING SETS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL FILTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL FILTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL FILTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL NEEDLES & CATHETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL NEEDLES & CATHETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL NEEDLES & CATHETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL APHERESIS DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL APHERESIS DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL APHERESIS DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL AUTOMATED APHERESIS MACHINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL AUTOMATED APHERESIS MACHINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL AUTOMATED APHERESIS MACHINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL SEMI-AUTOMATED APHERESIS MACHINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL SEMI-AUTOMATED APHERESIS MACHINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL SEMI-AUTOMATED APHERESIS MACHINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL CENTRIFUGATION TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL CENTRIFUGATION TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CENTRIFUGATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL MEMBRANE FILTRATION TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL MEMBRANE FILTRATION TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL MEMBRANE FILTRATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL HOLLOW FIBER FILTRATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL HOLLOW FIBER FILTRATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL HOLLOW FIBER FILTRATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL SELECTIVE PLASMA FILTRATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL SELECTIVE PLASMA FILTRATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL SELECTIVE PLASMA FILTRATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL ADSORPTION TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL ADSORPTION TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL ADSORPTION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL PHOTOPHERESIS TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL PHOTOPHERESIS TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL PHOTOPHERESIS TECHNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL BLOOD COLLECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL BLOOD COLLECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL PLASMA COLLECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL PLASMA COLLECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL PLASMA COLLECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL PLATELET COLLECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL PLATELET COLLECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL PLATELET COLLECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL RBC COLLECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL RBC COLLECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL RBC COLLECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL STEM CELL COLLECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL STEM CELL COLLECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL STEM CELL COLLECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL THERAPEUTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL THERAPEUTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL THERAPEUTIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL GUILLAIN-BARRE SYNDROME MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL GUILLAIN-BARRE SYNDROME MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL GUILLAIN-BARRE SYNDROME MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL MYASTHENIA GRAVIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL MYASTHENIA GRAVIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL MYASTHENIA GRAVIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL HEMATOLOGICAL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL HEMATOLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL HEMATOLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL LEUKEMIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL LEUKEMIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL LEUKEMIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL SICKLE CELL DISEASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL SICKLE CELL DISEASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL SICKLE CELL DISEASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL THROMBOCYTOPENIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL THROMBOCYTOPENIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL THROMBOCYTOPENIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL RENAL DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL RENAL DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL RENAL DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL KIDNEY FAILURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL KIDNEY FAILURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL KIDNEY FAILURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL GLOMERULONEPHRITIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL GLOMERULONEPHRITIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL GLOMERULONEPHRITIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL BLOOD BANKS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL BLOOD BANKS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL BLOOD BANKS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL PUBLIC HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2017-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2017-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2017-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2017-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 149. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 150. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 151. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2017-2032 (USD MILLION)
TABLE 152. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2017-2032 (USD MILLION)
TABLE 153. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 154. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 155. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 156. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 157. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2017-2032 (USD MILLION)
TABLE 158. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 159. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 160. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 161. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2017-2032 (USD MILLION)
TABLE 162. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 163. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 164. NORTH AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 165. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 166. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 167. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2017-2032 (USD MILLION)
TABLE 168. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2017-2032 (USD MILLION)
TABLE 169. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 170. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 171. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 172. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 173. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2017-2032 (USD MILLION)
TABLE 174. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 175. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 176. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 177. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2017-2032 (USD MILLION)
TABLE 178. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 179. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 180. LATIN AMERICA APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 181. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 182. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 183. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2017-2032 (USD MILLION)
TABLE 184. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2017-2032 (USD MILLION)
TABLE 185. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 186. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 187. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 188. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 189. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2017-2032 (USD MILLION)
TABLE 190. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 191. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 192. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 193. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2017-2032 (USD MILLION)
TABLE 194. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 195. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 196. EUROPE APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 197. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 198. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 199. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2017-2032 (USD MILLION)
TABLE 200. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2017-2032 (USD MILLION)
TABLE 201. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 202. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 203. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 204. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 205. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2017-2032 (USD MILLION)
TABLE 206. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 207. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 208. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 209. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2017-2032 (USD MILLION)
TABLE 210. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 211. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 212. MIDDLE EAST APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 213. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 214. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 215. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2017-2032 (USD MILLION)
TABLE 216. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2017-2032 (USD MILLION)
TABLE 217. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 218. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 219. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 220. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 221. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2017-2032 (USD MILLION)
TABLE 222. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 223. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 224. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 225. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2017-2032 (USD MILLION)
TABLE 226. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 227. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 228. AFRICA APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 229. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 230. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 231. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 232. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2017-2032 (USD MILLION)
TABLE 233. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2017-2032 (USD MILLION)
TABLE 234. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 235. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 236. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 237. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 238. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2017-2032 (USD MILLION)
TABLE 239. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 240. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 241. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 242. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2017-2032 (USD MILLION)
TABLE 243. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 244. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 245. ASEAN APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 246. GCC APHERESIS EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 247. GCC APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 248. GCC APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2017-2032 (USD MILLION)
TABLE 249. GCC APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2017-2032 (USD MILLION)
TABLE 250. GCC APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 251. GCC APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 252. GCC APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 253. GCC APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 254. GCC APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2017-2032 (USD MILLION)
TABLE 255. GCC APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 256. GCC APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 257. GCC APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 258. GCC APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2017-2032 (USD MILLION)
TABLE 259. GCC APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 260. GCC APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 261. GCC APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 262. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 263. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 264. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2017-2032 (USD MILLION)
TABLE 265. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2017-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 267. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2017-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 273. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 274. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2017-2032 (USD MILLION)
TABLE 275. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 276. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 277. EUROPEAN UNION APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 278. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 279. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 280. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2017-2032 (USD MILLION)
TABLE 281. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2017-2032 (USD MILLION)
TABLE 282. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 283. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 284. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 285. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 286. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2017-2032 (USD MILLION)
TABLE 287. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 288. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 289. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 290. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2017-2032 (USD MILLION)
TABLE 291. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 292. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 293. BRICS APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 294. G7 APHERESIS EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 295. G7 APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 296. G7 APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2017-2032 (USD MILLION)
TABLE 297. G7 APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2017-2032 (USD MILLION)
TABLE 298. G7 APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 299. G7 APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 300. G7 APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 301. G7 APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 302. G7 APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2017-2032 (USD MILLION)
TABLE 303. G7 APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 304. G7 APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 305. G7 APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 306. G7 APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2017-2032 (USD MILLION)
TABLE 307. G7 APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 308. G7 APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 309. G7 APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 310. NATO APHERESIS EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 311. NATO APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 312. NATO APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2017-2032 (USD MILLION)
TABLE 313. NATO APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2017-2032 (USD MILLION)
TABLE 314. NATO APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 315. NATO APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 316. NATO APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 317. NATO APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 318. NATO APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2017-2032 (USD MILLION)
TABLE 319. NATO APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 320. NATO APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 321. NATO APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 322. NATO APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2017-2032 (USD MILLION)
TABLE 323. NATO APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 324. NATO APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 325. NATO APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 326. GLOBAL APHERESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 327. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 328. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 329. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2017-2032 (USD MILLION)
TABLE 330. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2017-2032 (USD MILLION)
TABLE 331. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 332. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 333. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 334. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 335. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2017-2032 (USD MILLION)
TABLE 336. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 337. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 338. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 339. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY RENAL DISEASES, 2017-2032 (USD MILLION)
TABLE 340. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 341. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 342. UNITED STATES APHERESIS EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 343. CANADA APHERESIS EQUIPMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 344. CANADA APHERESIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 345. CANADA APHERESIS EQUIPMENT MARKET SIZE, BY DISPOSABLE APHERESIS KITS, 2017-2032 (USD MILLION)
TABLE 346. CANADA APHERESIS EQUIPMENT MARKET SIZE, BY APHERESIS DEVICES, 2017-2032 (USD MILLION)
TABLE 347. CANADA APHERESIS EQUIPMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2017-2032 (USD MILLION)
TABLE 348. CANADA APHERESIS EQUIPMENT MARKET SIZE, BY MEMBRANE FILTRATION TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 349. CANADA APHERESIS EQUIPMENT MARKET SIZE, BY PATIENT TYPE, 2017-2032 (USD MILLION)
TABLE 350. CANADA APHERESIS EQUIPMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 351. CANADA APHERESIS EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION, 2017-2032 (USD MILLION)
TABLE 352. CANADA APHERESIS EQUIPMENT MARKET SIZE, BY THERAPEUTIC, 2017-2032 (USD MILLION)
TABLE 353. CANADA APHERESIS EQUIPMENT MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 354. CANADA APHERESIS EQUIPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, 2017-2032 (USD MILLION)
TABLE 355. CA

Companies Mentioned

  • Aferetica srl
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun SE
  • Baxter International Inc.
  • Beijing ZKSK Technology Co., Ltd.
  • Bioelettronica S.r.l.
  • Cerus Corporation
  • Cytosorbents Corporation
  • Fresenius SE & Co. KGaA
  • Guangzhou Daji Medical Science and Technology Co., Ltd.
  • Haemonetics Corporation
  • Haier Biomedical
  • Infomed SA
  • Jafron Biomedical Co., Ltd.
  • Kaneka Corporation
  • Kawasumi Laboratories, Inc.
  • Macopharma SA
  • Medica S.p.A.
  • Miltenyi Biotec B.V. & Co. KG
  • Nikkiso Co., Ltd.
  • PuriBlood Medical Co., Ltd.
  • Terumo BCT, Inc.
  • Therakos, Inc.

Table Information

Report AttributeDetails
No. of Pages188
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.78 Billion
Forecasted Market Value ( USD ) by 2032 $ 6.45 Billion
Compound Annual Growth Rate9.3%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Apheresis Equipment Market Size, Share & Trends Analysis Report by Product, Application, Procedure, Region, and Segment Forecasts, 2026-2033 - Product Image

Apheresis Equipment Market Size, Share & Trends Analysis Report by Product, Application, Procedure, Region, and Segment Forecasts, 2026-2033

  • Report
  • 180 Pages
  • Global
From
Apheresis Equipment Market Size, Share, Trends and Forecast by Product, Application, Procedure, Technology, End User, and Region, 2026-2034 - Product Image

Apheresis Equipment Market Size, Share, Trends and Forecast by Product, Application, Procedure, Technology, End User, and Region, 2026-2034

  • Report
  • 149 Pages
  • Global
From
Apheresis Market by Product, Procedure, Application, Technology, End User - Global Forecast to 2031 - Product Image

Apheresis Market by Product, Procedure, Application, Technology, End User - Global Forecast to 2031

  • Report
  • 330 Pages
  • Global
From
Apheresis Equipment - Global Strategic Business Report - Product Image

Apheresis Equipment - Global Strategic Business Report

  • Report
  • 604 Pages
  • Global
From
Apheresis Market Report by Component, Product, Technology, Procedure, Application, End User, and Region 2026-2034 - Product Image

Apheresis Market Report by Component, Product, Technology, Procedure, Application, End User, and Region 2026-2034

  • Report
  • 136 Pages
  • Global
From

About the Apheresis Equipment Market

Apheresis Equipment is a type of medical device used to separate components of a patient's blood, such as plasma, platelets, and red blood cells. The process involves removing a portion of the patient's blood, separating the components, and then returning the remaining blood to the patient. Apheresis Equipment is used in a variety of medical applications, including the treatment of autoimmune diseases, cancer, and blood disorders. It is also used to collect blood components for transfusions and to remove toxins from the blood. Apheresis Equipment is typically composed of a centrifuge, a collection bag, and a monitor. The centrifuge is used to separate the components of the blood, while the collection bag is used to store the separated components. The monitor is used to monitor the patient's vital signs during the procedure. The Apheresis Equipment market is a growing segment of the medical device industry. It is expected to continue to grow as new applications are developed and the demand for blood components increases. Some companies in the Apheresis Equipment market include Fresenius Medical Care, Haemonetics Corporation, Terumo BCT, Asahi Kasei Medical, and Kawasumi Laboratories. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.